These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 22704951)

  • 1. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
    Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
    Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the new FIGO staging system (2009) for vulvar cancer in the Chinese population.
    Li J; Cai Y; Ke G; Xiang L; Wang L; Yang W; Wu X; Yang H
    Gynecol Oncol; 2015 May; 137(2):274-9. PubMed ID: 25759305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma.
    Tu H; Sun P; Gu HF; Zhang XK; Huang H; Wan T; Liu JH
    Eur J Surg Oncol; 2017 Sep; 43(9):1768-1775. PubMed ID: 28602173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of the number and laterality of metastatic inguinal lymph nodes in vulvar cancer: revisiting the FIGO staging system.
    Baiocchi G; Silva Cestari FM; Rocha RM; Lavorato-Rocha A; Maia BM; Cestari LA; Kumagai LY; Faloppa CC; Fukazawa EM; Badiglian-Filho L; Sant'ana Rodrigues I; Soares FA
    Eur J Surg Oncol; 2013 Jul; 39(7):780-5. PubMed ID: 23518307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical versus surgical staging systems in vulvar cancer.
    Shanbour KA; Mannel RS; Morris PC; Yadack A; Walker JL
    Obstet Gynecol; 1992 Dec; 80(6):927-30. PubMed ID: 1448261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A suggested modification to FIGO stage III vulvar cancer.
    Rouzier R; Preti M; Sideri M; Paniel BJ; Jones RW
    Gynecol Oncol; 2008 Jul; 110(1):83-6. PubMed ID: 18436291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of radical therapy in vulvar carcinoma. An analysis of 148 cases].
    Bokhman JV; Maximov SJ; Ebert AD
    Zentralbl Gynakol; 1997; 119(4):166-72. PubMed ID: 9206922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis.
    Greene FL; Stewart AK; Norton HJ
    J Clin Oncol; 2004 May; 22(10):1778-84. PubMed ID: 14769855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival.
    Kanazawa K; Suzuki T; Tokashiki M
    Gynecol Oncol; 1999 May; 73(2):237-41. PubMed ID: 10329040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?
    Cooke EW; Pappas L; Gaffney DK
    Cancer; 2011 Sep; 117(18):4231-7. PubMed ID: 21387282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison of clinical and surgical-pathologic staging of advanced vulvar cancer].
    Konefka T; Olszewski J; Makarewicz H; Emerich J
    Przegl Lek; 1999; 56(1):94-9. PubMed ID: 10375937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of an individualized surgical therapy of vulvar carcinoma from 1973-1993].
    Köhler U; Schöne M; Pawlowitsch T
    Zentralbl Gynakol; 1997; 119 Suppl 1():8-16. PubMed ID: 9245126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification.
    Werner HM; Trovik J; Marcickiewicz J; Tingulstad S; Staff AC; Amant F; Salvesen HB;
    Gynecol Oncol; 2012 Apr; 125(1):103-8. PubMed ID: 22100838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
    Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging and recurrence of disease in squamous cell carcinoma of the vulva.
    Ndubisi B; Kaminski PF; Olt G; Sorosky J; Singapuri K; Hackett T; Hetzel D; Zaino R; Mortel R; Podczaski E
    Gynecol Oncol; 1995 Oct; 59(1):34-7. PubMed ID: 7557612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: A comparison of the size of metastasis detected in inguinal lymph nodes.
    Robison K; Steinhoff MM; Granai CO; Brard L; Gajewski W; Moore RG
    Gynecol Oncol; 2006 Apr; 101(1):24-7. PubMed ID: 16246399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma.
    Pinto AP; Schlecht NF; Pintos J; Kaiano J; Franco EL; Crum CP; Villa LL
    Gynecol Oncol; 2004 Mar; 92(3):856-65. PubMed ID: 14984953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease.
    Farias-Eisner R; Cirisano FD; Grouse D; Leuchter RS; Karlan BY; Lagasse LD; Berek JS
    Gynecol Oncol; 1994 Apr; 53(1):55-8. PubMed ID: 8175023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.